Eileen Birch, Ph.D.
Director, Crystal Charity Ball Pediatric Vision Laboratory
Ph.D., University of California, 1979
Fellow, Massachusetts Institute of Technology, 1980-1982
Office: 214-363-3911 ext. 111
Pediatric Lab: 214-363-3911 ext. 113
Research:
Esotropia, Amblyopia, Hyperopia, Pediatric Cataracts, Retinopathy of Prematurity, Vision Screening, Infant Nutrition
Representative Publications:
Birch EE, Stager DR. Long-term motor and sensory outcomes following early surgery for infantile esotropia. JAAPOS, 2006, 10: 409-413.
Birch EE, Holmes JM. The clinical profile of amblyopia in children younger than 3 years of age. J AAPOS, 2010, 14: 494-7.
Birch EE, Stager Sr DR, Wang J, O’Connor AR. Longitudinal changes in refractive error of children with infantile esotropia,Eye, 2010, 24: 1814-21.
Birch E, Carlson S, Hoffman D, Fitzgerald-Gustafson K, Fu V, Drover J, Castañeda Y, Minns L, Wheaton D, Mundy D, Marunycz J, Diersen-Schade D. The DIAMOND study: A double masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr, 2010, 91: 848-59.
Wang J, Spencer R, Leffler J, Birch E. Critical period for foveal fine structure in children with regressed retinopathy of prematurity. Retina, 2012, 32:330-9.
Birch E, Cheng C, Stager Jr D, Weakley D, Stager Sr D. The critical period for surgical treatment of dense congenital bilateral cataracts. J AAPOS, 2009, 13: 67-71.
Mailing Address:
Eileen E. Birch, PhD
Retina Foundation of the Southwest
9600 N. Central Expressway, Suite 200
Dallas, TX 75231
USA
Related Articles
Clinical Center of Innovation for Age-Related Macular Degeneration Assessing Mobility Vision and Retinitis Pigmentosa Retina Foundation is Major Center for Next Phase of Gene Therapy for X-Linked Retinitis Pigmentosa: SKYLINE Retina Foundation’s Visionary Luncheon Celebrates Life‑Changing Advancements for Innovative Research and Vision Treatment Chance Encounter Leads to Early Diagnosis and Treatment for Kate
